Apathy and Related Disorders of Diminished Motivation



Apathy and Related Disorders of Diminished Motivation


James D. Duffy



Background


Historical Context

During the eighteenth and nineteenth centuries, disorders of motivation represented the theoretical foundation for most psychiatric classifications. The Swiss psychiatrist André Matthey wrote in 1816 that psychiatric illness was a manifestation of “perversions of the will and the natural inclinations without obvious impairment of the intellectual functions.” Matthey distinguished between a behavioral disturbance caused by a physical etiology (délire) and a behavioral disorder produced by a disturbance of the individual’s free will (fureur sans délire). According to Matthey’s nosology, behaviors such as kleptomania, ennui, melancholia, and tigridoanie (an irresistible urge to spill blood) were all considered “disorders of the will.” Matthey’s seminal writings became the foundation for the development of nineteenth-century neuropsychiatry and a clinical approach that placed disorders of will as the primary derangement in pathologic behaviors.

The German neuropsychiatrist Heinroth (1818) rejected earlier explanations for mental illness such as “bile or worms or a hundred other irritations” and suggested, “there are many involuntary movements, but not a single involuntary action, for action cannot be imagined without willing.” Heinroth went on to write that pathologic behaviors occurred when “the will separates itself from reason and is no longer determined by feeling or intellect.” By distinguishing intellect from
emotion and motivation, Heinroth laid the foundation for the triad approach of Mood, Cognition, and Conation that became the basis for psychiatric classification for the most part of the nineteenth century. The term abulia appeared in psychiatric literature as early as 1847 and was defined in medical dictionaries as “absence of will, a type of insanity in which this symptom is dominant.” Ribot described abulia as a “pure disease of will” in which the individual’s ability to act was abolished and he or she was reduced to an individual of “pure intellect.” Although most neuropsychiatrists at the end of the nineteenth century agreed on the concept of abulia, there was considerable disagreement on whether the disorder was caused by a deficit in cognition or was a consequence of a dysfunction in a specific motivational system within the brain.

By the beginning of the twentieth century, abulia had become a household word and parents were even urged to “combat the evil of abulia amongst students.” Despite this, the neuropsychiatric concept of disorders of will fell quickly into decline and by the end of World War I they had essentially disappeared from psychiatric nosology. The reasons for this shift include (i) the rise of behaviorism that posited a simple reflex response that did not require an intervening variable; (ii) psychiatry’s preoccupation with psychoanalysis and its emphasis of psychodynamic predeterminism; (iii) the burgeoning field of neurology with its emphasis on somatosensory disorders; (iv) the emergence of postmodernism and its emphasis on individuality and self-determinism (v) the reassignment of disorders of free will to diagnostic concepts such as “negative symptoms” and “executive cognition.”


Definitions of Motivation

A universal definition of the term motivation remains elusive. This single issue represents the most important barrier to our scientific attempts to understand the neural basis of goal-directed behavior and clinical disorders of motivation.

From a theoretical perspective, motivation is the heuristic construct that describes the amalgam of forces acting within an organism to initiate and direct behavior. Motivation serves to influence the activation, persistence, and direction of an organism’s behavioral response across different levels of behavioral complexity.

From a neuropsychiatric perspective, motivation describes the neurologically mediated variables that energize and direct an individual’s response to the environment. These variables include the following:



  • The emotional response to a stimulus


  • The motor reactivity to the stimulus


  • The level of arousal elicited by the stimulus


  • The cognitive interpretation of a stimulus

This approach provides a simple framework for assessing the character and etiology of behaviors that are characterized by a decrease in the expected response to a particular stimulus. It also provides a heuristic framework that is inclusive of and consistent with each of the different approaches to motivation described in the preceding text and does not fall prey to Cartesian models that attempt to separate mind-driven behaviors (i.e., free will) from homeostatic drive theories and instinctual reflex behavior patterns.



Definition of Apathy

Apathy may be either a symptom or a syndrome. As a syndrome, Marin has proposed Diagnostic and Statistical Manual of Mental Disorders (DSM)-like criteria (see subsequent text). Although not yet formally accepted, these criteria do provide the framework for the clinical assessment of apathy.

As per Marin’s proposed criteria, apathy is defined as “A lack of motivation, relative to the patient’s previous level of functioning or the standards of his/her age and culture as evidenced by all three of the following”:



  • Diminished goal-directed overt behavior, as indicated by the following:



    • Lack of productivity


    • Lack of effort


    • Lack of time spent in activities of interest


    • Lack of initiative or perseverance


    • Behavioral compliance or dependency on others


    • Diminished socialization or recreation


  • Diminished goal-directed cognition as indicated by the following:



    • Lack of interests


    • Lack of concern about one’s personal, health, or functional problems


    • Diminished importance or value attributed to such goal-related domains as socialization, recreation, productivity, initiative, curiosity


  • Diminished emotional concomitants of goal-directed behavior as indicated by the following:



    • Unchanging affect


    • Lack of emotional responsiveness


    • Euphoria or flat affect


    • Absence of excitement or emotional intensity


Classification of Apathy and Disorders of Motivation

Apathy and the Diagnostic and Statistical Manual of Mental Disorders text revision (DSM-IV-TR)—The DSM glossary does not include the term apathy, but related symptoms such as indifference, emotional unresponsiveness, lack of symptoms, and lack of concern are included in the diagnostic criteria and symptoms of several disorders. Further examples of related symptoms in DSM-IV-TR include the following:



  • Major depressive disorder: “Diminished interest or pleasure in all, or almost all, activities”


  • Post-traumatic stress disorder: “Markedly diminished interest or participation in significant activities”


  • Schizophrenia: Catatonic behavior characterized by “decrease in reactivity to the environment;” negative symptoms include avolition, alogia, and affective flattening

Apathy is explicitly included as a diagnostic criterion in only the following four disorders:



  • Inhalant intoxication (criterion B—“maladaptive changes e.g., apathy”)


  • Opioid intoxication (criterion B—“euphoria followed by apathy”)



  • Apathetic type of personality change due to a general medical condition (i.e., predominant feature is apathy or indifference)


  • Postconcussional disorder (criterion C—“apathy or lack of spontaneity”)


Epidemiology of Apathy and Disordered Motivation

No data are currently available on apathy as a primary disorder. However, a considerable amount of research indicates that apathy is perhaps the most common behavioral syndrome associated with neurologic disease. A recent analysis of prevalence data revealed that neurologic diseases involving the cerebral cortex are associated with a point prevalence of apathy of approximately 60%, whereas disorders primarily involving subcortical structures are associated with a 40% prevalence of apathy.



  • Alzheimer disease: At least six studies have examined the prevalence of apathy in Alzheimer disease (AD) with a reported prevalence ranging from 37% to 86.4% (composite prevalence 55.5%). Apathy has also been reported to be the most common behavioral symptom in mild cognitive impairment (MCI) with a point prevalence of 39%. It is important to recognize that apathy may be a herald symptom in MCI and AD that antedates the onset of observable cognitive decline. The prevalence of apathy in AD appears to be higher in community-dwelling AD patients and may be the most important determining factor for patients’ families seeking medical evaluation.


  • Traumatic brain injury: Several studies have reported the prevalence of apathy in traumatic brain injury (TBI) to range from 46% to 71% with a composite average of 61%. One study reported that apathy occurred in only 13.8% of patients following a TBI.


  • Vascular dementia: Two studies have reported a combined prevalence of 33.8% in a sample of patients with vascular dementia.


  • Poststroke: The prevalence of apathy in a heterogeneous group of patients following cerebrovascular accidents ranges from 22.5% to 56.7%. Apathy appears to be most frequent following a lesion involving the posterior limb of the internal capsule and is slightly higher in patients with right hemisphere lesions.


  • Anoxic encephalopathy: A study including 14 subjects reported a prevalence of 78.6% in patients with postanoxic encephalopathy.


  • Parkinson Disease: Using self report or informant-based measures, several studies have reported that between 16.5% and 42% of patients with Parkinson disease (PD) exhibit apathy. Low serum testosterone has been found to be an independent variable predicting the presence of apathy in PD.


  • Huntington disease: One study reported that 38% of patients with Huntington disease exhibit apathy and depression, with 7% exhibiting apathy alone. Apathy was found to be a powerful predictor of activities of daily living (ADL) ability.


  • Multiple sclerosis: Apathy has been reported to occur in 20.5% of patients with multiple sclerosis (MS); however, 53.3% of MS patients with depression are apathetic.


  • Human immunodeficiency virus: Three studies in patients with human immunodeficiency virus (HIV) report a prevalence ranging from 29.8% to 50%.
    Interestingly, the presence of apathy does not appear to correlate with absolute CD4 count.


  • Nursing home residents: Probably as a consequence of the additive effect of severity of disease and impoverished social environment, nursing home residents have an extremely high prevalence of apathy. This finding has important implications for patient compliance and undoubtedly negative impacts on disease progression, morbidity, and mortality.


  • Although no data is available, given their pathophysiology, it is reasonable to assume that normal pressure hydrocephalus, sleep apnea, amyotrophic lateral sclerosis, Lyme disease, and thyroid disease are associated with atrophy.


  • Negative symptoms of schizophrenia: The overlap between apathy and the negative symptoms of schizophrenia is discussed elsewhere in this text.


  • Prescription medications: Although no data is available on prevalence, anecdotal reports indicate that apathy may occur as a side-effect of selective serotonin reuptake inhibitors (SSRIs), neuroleptics, metaclopramide, and felbamate.


Prognosis

Several studies have reported significant morbidity associated with the presence of apathy. Four studies in patients with Alzheimer dementia that utilized standardized assessment tools for the diagnosis of apathy, have reported an association between the presence of apathy and diminished performance on activities of daily living (independent of the presence of depression). Patients who are apathetic following a stroke have been reported to be more functionally impaired, with the comorbidity of apathy and depression having the greatest impact on functional capacity. A study of geriatric patients admitted to a nursing home found apathy to be an important predictor of functional capacity at discharge, independent of admission diagnosis.

Apathy appears to be associated with more rapid cognitive and functional decline in patients with AD. Apathy has also been reported to be an important predictor of poor prognosis in patients with major depressive disorders.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Oct 2, 2016 | Posted by in PSYCHIATRY | Comments Off on Apathy and Related Disorders of Diminished Motivation

Full access? Get Clinical Tree

Get Clinical Tree app for offline access